Hessekiel Jeffrey 4
4 · CYTOKINETICS INC · Filed Nov 17, 2025
Insider Transaction Report
Form 4
CYTOKINETICS INCCYTK
Hessekiel Jeffrey
Chief Legal & Admin Officer
Transactions
- Award
Common Stock
2025-11-14+87,297→ 87,297 total
Footnotes (1)
- [F1]Initial new hire grant comprised of restricted stock units ("RSUs") that are convertible to shares of common stock on a 1:1 basis upon vesting. RSUs will vest as follows: 40% of the aggregate RSUs on the date falling 1-year from the date of grant, an additional 40% of the aggregate RSUs on the date falling 2-years from the date of grant, and the remaining 20% of the aggregate RSUs on the date falling 3-years from the date of grant, in each case subject to Mr. Hessekiel's continued employment with Cytokinetics.